Introduction: Alcohol dependence is characterized by a reduction in reward threshold, development of a negative affective state, and significant cognitive impairments. Dependence-induced glutamatergic neuroadaptations in the neurocircuitry mediating reward, affect and cognitive function are thought to underlie the neural mechanism for these alterations. These changes serve to promote increased craving for alcohol and facilitate the development of maladaptive behaviors that promote relapse to alcohol drinking during periods of abstinence. Objective: To review the extant literature on the effects of chronic alcohol exposure on glutamatergic neurotransmission and its impact on reward, affect and cognition. Results: Evidence from a diverse set of studies demonstrates significant enhancement of glutamatergic activity following chronic alcohol exposure. In particular, up-regulation of GluN2B-containing NMDA receptor expression and function is a commonly observed phenomenon that likely reflects activity-dependent adaptive homeostatic plasticity. However, this observation as well as other glutamatergic neuroadaptations are often circuit and cell-type specific. Discussion: Dependence-induced alterations in glutamate signaling contribute to many of the symptoms experienced in addicted individuals and can persist well into abstinence. This suggests that they play an important role in the development of behaviors that increase the probability for relapse. As our understanding of the complexity of the neurocircuitry involved in the addictive process has advanced, it has become increasingly clear that investigations of cell-type and circuit-specific effects are required to gain a more comprehensive understanding of the glutamatergic adaptations and their functional consequences in alcohol addiction. Conclusion: While pharmacological treatments for alcohol dependence and relapse targeting the glutamatergic system have shown great promise in preclinical models, more research is needed to uncover novel, possibly circuit-specific, therapeutic targets that exhibit improved efficacy and reduced side effects.
Introduction
Alcohol dependence is a chronic relapsing disorder characterized by repeated episodes of withdrawal and relapse to heavy alcohol consumption. This repetitive process promotes the development of maladaptive behaviors through neural adaptations that ultimately serve to facilitate continued drinking and hinder long-term abstinence. A substantial body of work has focused on the role of dopaminergic changes in promoting continued alcohol consumption. However, it has become apparent that adaptations in the dopamine system are not solely responsible for the increased propensity for relapse that occurs as a result of alcohol dependence. In particular, accumulating evidence indicates that aberrant glutamatergic-based plasticity plays a critical role in alcohol addiction and relapse. Early evidence for the involvement of the glutamatergic system in alcohol dependence and alcohol-related behaviors stemmed from the efficacy of NMDA receptor antagonists in alleviating seizures and other symptoms of acute withdrawal (Hoffman et al., 1990) and evidence later emerged pointing to glutamate's role in reward regulation (Taber and Fibiger, 1995) . During this same time, in vitro work examining the effects of chronic ethanol exposure in neuronal culture systems also revealed a direct effect of ethanol on the NMDA receptor (Chandler et al., 1998; Chandler, 2003) that has subsequently been confirmed in vivo (Burnett et al., 2014; Szumlinski and Woodward, 2014) . Together, these findings sparked intense interest Abbreviations: AMPA, 2-amino-3(3-hydroxy-5-methyl-isoxazol-4yl)propanoic acid; BNST, bed nucleus of the stria terminalis; CeA, central nucleus of the amgydala; CSF, cerebrospinal fluid; DLS, dorsolateral striatum; DMS, dorsomedial striatum; EC, external capsule; EPSP, excitatory postsynaptic potential; iGluR, ionotropic glutamate receptor; GluA1-4, AMPA receptor subunits; GluK1-3, kainate receptor subunits; GluN1-3, NMDA receptor subunits; LHb, lateral habenula; LTD, long-term depression; LTP, long-term potentiation; MeA, medial nucleus of the amygdala; mGluR, metabotropic glutamate receptor; mPFC, medial prefrontal cortex; MSN, medium spiny neuron; NAc, nucleus accumbens; NMDA, N-methyl-D-asparate; OFC, orbitofrontal cortex; PAG, periacqueductal gray; PFC, prefrontal cortex; PrL, prelimbic cortex; RMTg, rostromedial tegmental nucleus; VTA, ventral tegmental area.
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